- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
Status
Planned
Phase
Demo Project
Principal Investigator(s)
Raphael Landovitz, MD
Objective
The purpose of this study is to test a program that uses drug level monitoring, text messaging ("iTAB") and personalized counseling with HIV prevention services, including PrEP (medicine that can help prevent HIV infection when taken daily)
Prevention Option(s)
PrEP
Study Design
Open label
Arms and Assigned Interventions
Description
ing/Counseling
All participants assigned to the iTAB intervention will receive daily dosing reminders that will be sent for the first 6 weeks and then continue with reminders for the duration of the study.
Other Name: iTAB
Behavioral: Text Messaging/Counseling
All participants assigned to the counseling intervention will receive sexual health and medication adherence counseling at each study visit. Participants with suboptimal adherence (TFV-DP levels of <1050 fmol/punch (representing fewer than mean 6-7 daily doses per week)) will trigger a targeted iNSC session. Participants with two TFV-DP levels of <1050 fmol/punch will trigger PrEP Steps, a higher intensity adherence counseling intervention consisting of four 50-minute counseling sessions and 2 booster counseling sessions.
Other Names:
Integrate Next Step Counseling (iNSC)
Targeted iNSC
PrEP Steps
Products
TDF
ARMs
Experimental
Official Code
Trial Sponsors
California HIV/AIDS Research Program of the University of California; Gilead Sciences
Product Developers
California Collaborative Treatment Group; University of California, San Diego; UCLA; University of Southern California; City of Long Beach Department of Health and Human Services
January 2016
January 2018
Enrollment
100
18
Years
Population
Women
Sites
UCSD Antiviral Research Center
San Diego, California
United States of America
Los Angeles Biomedical Research Institute at Harbor-UCLA
Los Angeles, California
United States of America
USC 5P21 Rand Schrader Clinic
Los Angeles, California
United States of America
APLA Health & Wellness' Gleicher / Chen Health Center
Los Angeles, California
United States of America